Novartis and MMV Unveil Promising Malaria Treatment Data for Infants Under 5 Kilograms
Apr 25, 2024
Novartis Invest Advisor
Novartis Secures FDA Approval for PNH Treatment Fabhalta
Dec 7, 2023